Clinical Trials Logo

Heart Valve Diseases clinical trials

View clinical trials related to Heart Valve Diseases.

Filter by:

NCT ID: NCT01972555 Completed - Clinical trials for Aortic Valve Stenosis

Cardiac Function After Minimally Invasive Aortic Valve Implantation

CMILE
Start date: October 2013
Phase: N/A
Study type: Interventional

This is a single-center, open-label, randomized controlled trial. Patients scheduled for aortic valve replacement (AVR) at Karolinska University Hospital in Stockholm, Sweden will be eligible. Forty patients will be randomly assigned to either minimally invasive (20 patients) or conventional AVR (20 patients). CE-marked and FDA-approved mechanical and bioprosthetic aortic valves (conventional stented or sutureless bioprostheses) will be implanted. Transthoracic echocardiography will be performed before surgery, and at day 1, 4, and 40. Echocardiographic parameters as well as preoperative clinical characteristics and postoperative clinical outcomes will be registered. Routine blood sampling will be performed pre- and postoperatively. All available data will be collected prospectively. Informed consent will be obtained from patients meeting the inclusion criteria before the initiation of any study-specific procedures.

NCT ID: NCT01826149 Completed - Clinical trials for Coronary Artery Disease

Propofol Effects on Mitral Valve Annular Velocity

Start date: April 2013
Phase: Phase 4
Study type: Interventional

The purpose of this study is primarily to determine the effects of propofol at different concentration on the mitral valve annulus by using Tissue Doppler Imaging

NCT ID: NCT01825720 Completed - Clinical trials for Valvular Heart Disease

Effect of Glucose-Insulin-Potassium on Hyperlactatemia in Patients Undergoing Valvular Heart Surgery

Start date: March 2013
Phase: N/A
Study type: Interventional

Hyperlactatemia, occuring 10-20% in patients undergoing valvular heart surgery, is known to be associated with hemodynamic instability, organ dysfunction and increased postoperative morbidity and mortality. Glucose-Insulin-Potassium(GIK) has been constantly used as an adjuvant therapy in patients with myocardial infarction or in the patients undergoing valvular heart surgery to reduce the low cardiac output syndrome and mortality. GIK is known to prevent excretion of lactate and to increase the extraction of lactate after reperfusion with various mechanism. In addition, it is also known to decrease ischemic-reperfusion injury of myocardium after CPB, to improve myocardial contractility, insulin resistance and hyperglucemia. As a result, it brings hemodynamic stability and sufficient oxygen supply to the tissue, which might reduce the incidence of hyperlactatemia after valvular heart surgery.

NCT ID: NCT01823432 Completed - Clinical trials for Bicuspid Aortic Valve

Genetic Risks for Bicuspid Aortic Valve Disease

Start date: March 2012
Phase:
Study type: Observational [Patient Registry]

Bicuspid Aortic Valve (BAV) is the most common congenital heart malformation in adults, but very little is known about the genetic causes or risk factors for adverse outcomes. Currently, it is estimated that most cases of aortic stenosis in patients less than 65 years old are caused by BAVs. BAV patients are also at high risk to develop aneurysms of the ascending aorta, which may lead to aortic dissections. Dr. Prakash and his colleagues plan to use individual genetic information to identify persons with BAV who are at high risk for complications and to customize therapies.

NCT ID: NCT01819012 Completed - Clinical trials for Ischemic Heart Disease

Effect of Isoflurane on Tissue Doppler Imaging of Mitral Annulus During Cardiac Surgery

Start date: March 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to determine Isoflurane's dose-dependent effect on left ventricular (LV) systolic function in cardiac surgery. The change of tissue Doppler imaging (TDI) of lateral mitral valve annular systolic velocity at three different isoflurane concentrations would be analyzed by using intraoperative transesophageal echocardiography (TEE) in cardiac surgery patients.

NCT ID: NCT01802619 Completed - Clinical trials for Heart Valve Diseases

Prevention of Renal Failure by Nitric Oxide in Prolonged Cardiopulmonary Bypass.

Start date: August 2013
Phase: Phase 1/Phase 2
Study type: Interventional

Prolonged periods of cardiopulmonary bypass (CPB) cause high levels of plasma free haemoglobin(Hb) and are associated with increased morbidity. We hypothesized that repletion of nitric oxide (NO) during and after the surgical procedure on CPB may protect against endothelium dysfunction and organ failure caused by plasma-Hb induced NO scavenging.

NCT ID: NCT01784055 Completed - Clinical trials for Cardiovascular Diseases

NeoChord TACT Post-Market Surveillance Registry

Start date: March 2013
Phase:
Study type: Observational [Patient Registry]

To monitor the long-term performance of the CE Marked NeoChord Artificial Chordae Delivery System

NCT ID: NCT01760668 Completed - Turner Syndrome Clinical Trials

Aortopathy in Persons With Bicuspid Aortic Valve, Turner and Marfan Syndrome

Start date: February 2013
Phase: N/A
Study type: Observational

The study aim is: 1. To examine aortic tissue by light microscopy 2. To examine aortic tissue by electron microscopy 3. To study changes in the epigenome and transcriptome of the X chromosome specific to aortic tissue. 4. To examine aortic tissue using biochemistry including proteomics. 5. To establish the karyotype of fibroblasts with standard chromosome examination on 10 meta-phases as well as by fluorescent in situ hybridization (FISH) with probes covering the X and Y chromosome. Using the latter 200 meta-phases will be examined. 30 controls who did not die from aortic dissection or dilation will be recruited from The Department of Forensic Medicine at Aarhus University Hospital. The investigators will subject samples of aortic tissue from women undergoing prophylactic aortic surgery due to either Marfan syndrome or bicuspid aortic valve to the same panel of examinations (except karyotyping). Lastly the investigators will compare the results from the three groups (Turner syndrome, Marfan syndrome and Bicuspid aortic valve).

NCT ID: NCT01704482 Completed - Renal Dysfunction Clinical Trials

N-acetylcysteine for Renal Protection in Patients With Rheumatic Heart Disease Undergoing Valve Replacement

Start date: February 2011
Phase: Phase 2
Study type: Interventional

We aim to investigate the efficacy of N-acetylcysteine (NAC) to attenuate acute renal dysfunction in patients with rheumatic valvular heart disease undergoing single valve replacement.

NCT ID: NCT01685554 Completed - Clinical trials for Heart Valve Diseases

Normothermiс Cardiopulmonary Bypass Increases Cerebral Oxygenation During Valve Surgery

Start date: March 2010
Phase: N/A
Study type: Interventional

The aim of our study was to evaluate the effect of different temperature regimens of cardiopulmonary bypass on systemic oxygen transport and cerebral oxygenation during surgical correction of acquired heart diseases.